Blafar Ltd. is participating an Innovative Training Network Consortium named as 'Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications: developing new anti-bacterial therapies based on biomedical polymers and inorganic materials', which the abbreviation is 'HyMedPoly'. This consortium is funded by European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie Actions grant. More information about HyMedPoly can be found on the website: www.hymedpoly.eu.
On behalf of the consortium, Blafar Ltd. is pleased to host an open workshop event on 21st June in the Charles Institute of Dermatology on UCD campus. The topic of this workshop is 'from Science to Products'. Please click here for the full program. At the workshop, the consortium will showcase their recent research findings on the development of new anti-bacterial therapies based on biomedical polymers and inorganic materials, and also demonstrate their visions on how to translate Science into Products.
We welcome all parties interested in Drug-Free Antibacterial Hybrid Biopolymers to join this exciting half-day event. For free registration, please send email to [email protected].